fbpx

Live Cell Encapsulation: Worldwide Market Insights Report, 2019 – Alginate to Dominate, Majorly Due to the Procedural Benefits Offered – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Live
Cell Encapsulation Market by Technique (Dripping (Simple,
Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate,
Chitosan, Silica, Cellulose Sulfate), Application (Probiotics,
Transplant, Drug Delivery, Research) – Forecast to 2024”
report
has been added to ResearchAndMarkets.com’s offering.

The global live cell encapsulation market is projected to reach USD 303
million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%.

The growth of this market is majorly driven by factors such as the
ongoing technological advancements in live cell encapsulation, growing
public-private investments in the field of live cell encapsulation,
increasing number of target patient population, and the rising awareness
related to the clinical role of encapsulated cells in disease management.

However, the limited availability of high-quality raw materials, and the
significant adoption of alternative therapies are expected to restrain
the growth of this market during the forecast period.

“The electrostatic dripping segment to witness the highest
growth rate in the live cell encapsulation market, by manufacturing
technique”

Based on manufacturing technique, the live cell encapsulation market is
segmented into simple dripping, electrostatic dripping, coaxial airflow,
liquid-jet break-up, vibrating-jet technique, jet cutting, and rotating
disk atomization.

The electrostatic dripping segment is expected to account for the high
growth rate of this market in 2018, owing to the growing demand for
electrostatic dripping as a result of the procedural benefits such as
retention of cell viability & potency, and preservation of plant
oxidants.

“Alginate segment to witness the highest growth rate in the
live cell encapsulation market, by polymer type”

Based on polymer type, the live cell encapsulation market has been
segmented into alginate, HEMA-MMA (hydroxyethyl methacrylate-methyl
methacrylate), chitosan, siliceous encapsulates, cellulose sulfate,
PAN-PVC [poly (acrylonitrile vinyl chloride)], and other polymers.

The alginate segment is estimated to grow at the highest CAGR during the
forecast period majorly due to the procedural benefits offered such as
the capability to encapsulate living cells with wide pore size
distribution (5-200 nm) and high permeability of alginate.

“The drug therapy segment to account for the largest share
of the live cell encapsulation market, by application, in 2018”

Based on application, the live cell encapsulation market is segmented
into drug delivery, regenerative medicine, cell transplantation,
probiotics, and research.

The drug delivery segment is expected to account for the largest share
of the live cell encapsulation market in 2018. The growth of this
application segment can be attributed to the rising incidence of target
diseases and increasing research activities on live cell encapsulation
in major countries across the globe.

“The North America market to grow at the highest CAGR during
the forecast period”

The live cell encapsulation market is segmented into five major regions,
namely, North America, Europe, the Asia Pacific, Latin America, and the
Middle East and Africa.

The North America market is expected to grow at the highest CAGR during
the forecast period majorly due to the increasing research activities in
the field of cell encapsulation coupled with the growing public-private
investments for cell encapsulation research practices. Furthermore, the
increasing clinical data for the efficacy of the cell encapsulation
technique and the rising adoption of cell encapsulation techniques among
medical professionals are the other factors supporting the growth of
this market.

Key Topics Covered

1 Introduction
1.1 Objectives of the Study
1.2
Market Definition
1.3 Market Scope
1.4 Currency Used for the
Study
1.5 Major Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1
Secondary Data
2.1.1.1 Major Secondary Sources Referred
2.1.2
Primary Data
2.2 Market Estimation Methodology
2.2.1
Procedure-Based Market Estimation
2.2.2 Revenue Mapping-Based
Market Estimation
2.2.3 Primary Research Validation
2.3 Data
Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary

4 Premium Insights
4.1 Live Cell Encapsulation
Market Overview
4.2 Europe: Live Cell Encapsulation Market, By
Polymer Type
4.3 Global Live Cell Encapsulation Market, By Technique
4.4
Live Cell Encapsulation Market, By Application
4.5 Live Cell
Encapsulation Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market
Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Target
Diseases
5.2.1.2 Focus on Novel Drug Delivery Systems for Disease
Treatment
5.2.1.3 Technology Advancements
5.2.1.4 Increasing
Public-Private Investments to Support Novel Product Development
5.2.1.5
Rising Public Awareness Related to the Clinical Role of Encapsulated
Cells in Disease Management
5.2.2 Restraints
5.2.2.1 High
Product Manufacturing Costs
5.2.2.2 Limited Market Availability of
High-Quality Raw Materials
5.2.3 Opportunities
5.2.3.1 Rising
Research Activity
5.2.4 Challenges
5.2.4.1 Adoption of
Alternative Therapies

6 Live Cell Encapsulation Market, By Manufacturing Techniques
6.1
Introduction
6.2 Simple Dripping
6.3 Electrostatic Dripping
6.4
Coaxial Airflow
6.5 Liquid-Jet Break-Up
6.6 Vibrating-Jet
Technique
6.7 Jet Cutting
6.8 Rotating Disk Atomization

7 Live Cell Encapsulation Market, By Polymer Type
7.1
Introduction
7.2 Alginate
7.3 Hema-Mma
7.4 Chitosan
7.5
Siliceous Encapsulates
7.6 Cellulose Sulfate
7.7 PAN-PVC
7.8
Other Polymers

8 Live Cell Encapsulation Market, By Application
8.1
Introduction
8.2 Drug Delivery
8.3 Regenerative Medicine
8.4
Cell Transplantation
8.5 Probiotics
8.6 Research

9 Live Cell Encapsulation Market, By Region
9.1
Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5
Latin America
9.6 Middle East & Africa

10 Competitive Landscape
10.1 Overview
10.2
Global Market Share Analysis (2017)
10.3 Competitive Scenario (2015
to 2019)
10.4 Competitive Leadership Mapping
10.4.1 Vendor
Inclusion Criteria
10.4.1.1 Visionary Leaders
10.4.1.2
Innovators
10.4.1.3 Dynamic Differentiators
10.4.1.4 Emerging
Companies

11 Company Profiles
(Business Overview,
Products Offered, Recent Developments, View)

11.1 Introduction
11.2
Balchem Corporation
11.3 Biotime Inc.
11.4 Blacktrace Group
11.5
BUCHI Labortechnik AG
11.6 Encapsys LLC
11.7 Evonik Industries
11.8
Living Cell Technologies
11.9 Lycored
11.10 Merck KGaA
11.11
MiKroCaps
11.12 Neurotech Holdings LLC
11.13 Reed Pacific Pty.
Limited
11.14 Sernova Corporation
11.15 Sigilon Therapeutics
11.16
Viacyte Inc.

For more information about this report visit https://www.researchandmarkets.com/r/z8sagj

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biomaterials

leverton

Content is the most important part of having quality links to your website. With Area-Info.net, we provide a quality location to share your story and include links to your website to help you grow. If you would like to learn more, visit this page to see how you can use Area-Info.net to rank higher and quicker in search engines. Contact me directly at [email protected] with any questions, or to schedule speaking engagements.

You May Also Like